JPRN-UMIN000040862招募中未知
Consumption of cholesterol in nonalcoholic fatty liver disease (NAFLD): A multicenter cross sectional study - Consumption of cholesterol in nonalcoholic fatty liver disease (NAFLD): A multicenter cross sectional study
Department of Molecular Biochemistry & Clinical Investigation, Osaka University Graduate School of Medicine0 个研究点目标入组 200 人开始时间: 2020年6月23日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) History of chronic hepatic disease (viral hepatic disease, autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis (2) Hepatocellular carcinoma and other malignant diseases (3) Patients judged inappropriate by doctor or investigator
研究者
相似试验
已完成
4 期
Therapeutic effects of cholesterol absorption inhibitor on renal function in patients with chronic kidney diseaseChronic kidney disease HypercholesterolemiaJPRN-UMIN000002528Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine50
已完成
不适用
Effect of dietary lipid modification on nonalcoholic fatty liver disease in carriers of the PNPLA3 I148M genetic variant: an open label trialK76.0Fatty (change of) liver, not elsewhere classifiedDRKS00007781Saarland University Medical Center20
已完成
Unknown
Effects of consumption of structured lipid on the oral environment in healthy Japanese subjectsHealthy Japanese subjectsJPRN-UMIN000052398ORTHOMEDICO Inc.68
已完成
不适用
Cholesterol Absorption and Cholesterol synthesis in High-risk patiEnts (CACHE study)1. Cardiovascular disease (coronary arterial disease, cerebrovascular disease, peripheral arterial disease) 2. Conditions at high risk of cardiovascular disease (diabetes mellitus, chronic kidney disease including stage 5D) 3. Those who do not have the above diseasesJPRN-UMIN000030635Osaka City University3,000
招募中
不适用
Serum levels of Cholesterol synthesis/absorption markers in subjects of various diseases.ormal subjects, Diabetes, Hyperlipidemia, Essential hypertension, Metabolic syndromeJPRN-UMIN000004946Department of Metabolic Medicine, Faculty of life sciences, Kumamoto University600